2016年初,医药领域内发生了两件值得关注的事情。同年2月,国家食品药品监督管理总局宣布取消中药材GAP认证。仅1个月后,价值数亿元的疫苗未经冷藏就流入18个省份的消息被公开。这两件大事,再一次引发了人们对我国一些药品认证制度存废的讨论,其中强制GSP认证首当其冲。这些人认为,强制药品经营企业进行GSP认证与保证 In the early 2016, two things of concern happened in the medical field. In February the same year, the State Food and Drug Administration announced the cancellation of Chinese herbal medicine GAP certification. In just one month, the news that hundreds of millions of dollars of vaccines have flowed into 18 provinces without refrigeration has been made public. These two major events have once again raised the people’s discussion on the extinction of certain drug certification systems in China, of which the mandatory GSP certification bear the brunt. These people think that compulsory drug companies run GSP certification and assurance